Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, United States.
Nutritional Sciences and Toxicology, University of California, Berkeley, CA, United States.
Adv Nutr. 2024 Feb;15(2):100164. doi: 10.1016/j.advnut.2023.100164. Epub 2023 Dec 20.
Choline is essential for proper liver, muscle, brain, lipid metabolism, cellular membrane composition, and repair. Understanding genetic determinants of circulating choline metabolites can help identify new determinants of choline metabolism, requirements, and their link to disease endpoints. We conducted a scoping review to identify studies assessing the association of genetic polymorphisms on circulating choline and choline-related metabolite concentrations and subsequent associations with health outcomes. This study follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement scoping review extension. Literature was searched to September 28, 2022, in 4 databases: Embase, MEDLINE, Web of Science, and the Biological Science Index. Studies of any duration in humans were considered. Any genome-wide association study (GWAS) investigating genetic variant associations with circulating choline and/or choline-related metabolites and any Mendelian randomization (MR) study investigating the association of genetically predicted circulating choline and/or choline-related metabolites with any health outcome were considered. Qualitative evidence is presented in summary tables. From 1248 total reviewed articles, 53 were included (GWAS = 27; MR = 26). Forty-two circulating choline-related metabolites were tested in association with genetic variants in GWAS studies, primarily trimethylamine N-oxide, betaine, sphingomyelins, lysophosphatidylcholines, and phosphatidylcholines. MR studies investigated associations between 52 total unique choline metabolites and 66 unique health outcomes. Of these, 47 significant associations were reported between 16 metabolites (primarily choline, lysophosphatidylcholines, phosphatidylcholines, betaine, and sphingomyelins) and 27 health outcomes including cancer, cardiovascular, metabolic, bone, and brain-related outcomes. Some articles reported significant associations between multiple choline types and the same health outcome. Genetically predicted circulating choline and choline-related metabolite concentrations are associated with a wide variety of health outcomes. Further research is needed to assess how genetic variability influences choline metabolism and whether individuals with lower genetically predicted circulating choline and choline-related metabolite concentrations would benefit from a dietary intervention or supplementation.
胆碱对肝脏、肌肉、大脑、脂质代谢、细胞膜组成和修复至关重要。了解循环胆碱代谢物的遗传决定因素有助于确定新的胆碱代谢、需求及其与疾病终点的联系。我们进行了范围界定审查,以确定评估遗传多态性对循环胆碱和胆碱相关代谢物浓度的影响及其与健康结果随后关联的研究。本研究遵循系统评价和荟萃分析的首选报告项目范围界定审查扩展。文献检索至 2022 年 9 月 28 日,在 4 个数据库中进行:Embase、MEDLINE、Web of Science 和生物科学索引。考虑了任何持续时间的人类研究。任何研究遗传变异与循环胆碱和/或胆碱相关代谢物之间关联的全基因组关联研究(GWAS)以及任何孟德尔随机化(MR)研究,调查遗传预测的循环胆碱和/或胆碱相关代谢物与任何健康结果之间的关联,都被认为是符合条件的。定性证据以摘要表形式呈现。在 1248 篇综述文章中,有 53 篇被纳入(GWAS=27;MR=26)。在 GWAS 研究中,有 42 种循环胆碱相关代谢物与遗传变异相关联进行了测试,主要是三甲胺 N-氧化物、甜菜碱、鞘磷脂、溶血磷脂酰胆碱和磷脂酰胆碱。MR 研究调查了 52 种总独特胆碱代谢物和 66 种独特健康结果之间的关联。其中,在 16 种代谢物(主要是胆碱、溶血磷脂酰胆碱、磷脂酰胆碱、甜菜碱和鞘磷脂)和 27 种健康结果(包括癌症、心血管、代谢、骨骼和大脑相关结果)之间报告了 47 个显著关联。一些文章报告了多种胆碱类型与同一健康结果之间的显著关联。遗传预测的循环胆碱和胆碱相关代谢物浓度与多种健康结果相关。需要进一步研究来评估遗传变异性如何影响胆碱代谢,以及循环胆碱和胆碱相关代谢物浓度较低的个体是否会受益于饮食干预或补充。